Provided by Tiger Fintech (Singapore) Pte. Ltd.

SpringWorks Therapeutics, Inc.

46.16
-0.0700-0.15%
Volume:7.29M
Turnover:337.14M
Market Cap:3.43B
PE:-13.26
High:46.26
Open:46.23
Low:46.15
Close:46.23
Loading ...

Biotech Alert: Searches spiking for these stocks today

TipRanks
·
02 May

SpringWorks Therapeutics Cut to Neutral From Buy by HC Wainwright & Co.

Dow Jones
·
30 Apr

HC Wainwright Downgrades Springworks Therapeutics to Neutral From Buy, Adjusts Price Target to $47 From $74

MT Newswires Live
·
30 Apr

SpringWorks Therapeutics, Inc. : H.c. Wainwright Cuts to Neutral From Buy

THOMSON REUTERS
·
30 Apr

SpringWorks Therapeutics Cut to Hold From Buy by TD Cowen

Dow Jones
·
29 Apr

SpringWorks Therapeutics Inc : Barclays Cuts Target Price to $47 From $63

THOMSON REUTERS
·
29 Apr

SpringWorks Therapeutics Inc : Barclays Cuts to Equal-Weight From Overweight

THOMSON REUTERS
·
29 Apr

U.S. RESEARCH ROUNDUP-Domino's Pizza, Prologis, Springworks Therapeutics

Reuters
·
29 Apr

BUZZ-U.S. STOCKS ON THE MOVE-Marriott, Wells Fargo, Insulet

Reuters
·
28 Apr

Piper says SpringWorks deal suggests Immunome’s varegacestat ‘undervalued’

TIPRANKS
·
28 Apr

Merck KGaA's $3.9B SpringWorks Therapeutics Buy Underwhelms -- Market Talk

Dow Jones
·
28 Apr

SpringWorks Therapeutics Shares up 3.2% After Merck KGaA to Buy Co in $3.9 Bln Deal

THOMSON REUTERS
·
28 Apr

BUZZ-U.S. STOCKS ON THE MOVE-Domino's Pizza, Eli Lilly, Revvity

Reuters
·
28 Apr

Wedbush Downgrades Springworks Therapeutics to Neutral From Outperform, Adjusts PT to $47 From $81

MT Newswires Live
·
28 Apr

5 Things to Know Before the Stock Market Opens

Investopedia
·
28 Apr

Merck KGaA CEO Says Our M&a Strategy Will Remain Very Disciplined, Life Science Unit to Remain a Focus

THOMSON REUTERS
·
28 Apr

Deals of the day - Mergers and acquisitions

Reuters
·
28 Apr

Springworks Therapeutics Agrees to $47-Per-Share Takeover Offer From Germany's Merck

MT Newswires Live
·
28 Apr

PRESS DIGEST - Wall Street Journal - April 28

Reuters
·
28 Apr

Germany's Merck KGaA in $3.9 billion deal to buy US biotech firm SpringWorks

Reuters
·
28 Apr